Women who have had a Bard/Avaulta® vaginal mesh implanted to treat pelvic organ prolapse could be at risk for severe internal injuries, urinary problems, and other complications. Bard Avaulta lawsuits allege that the defective design of the device may increase the risk of infections, erosion, and other painful complications.
Vaginal Mesh Lawsuit Update 7/26/12: Last Friday, a jury ruled that medical technology giant C.R. Bard and a doctor must pay a total of $5.5 million in damages over a vaginal mesh implant that left a woman with persistent pain and potentially irreversible injuries.The landmark case is the first to go to trial among hundreds of lawsuits alleging that vaginal mesh implants made by Bard, Johnson & Johnson, and Boston Scientific caused severe organ damage and other serious injuries. Click here to learn more.
Transvaginal Mesh Lawsuit Update 6/21/12: A judge has lifted the discovery stay in the federal transvaginal mesh (TVM) litigation, as scores of new cases continue to be filed on behalf of women in courthouses around the country. All discovery was stayed earlier this year in federal lawsuits involving transvaginal mesh products used for surgical repair of pelvic organ prolapse (POP) and stress urinary incontinence (SUI). Click here to learn more.
Vaginal Mesh Lawsuit Update 5/16/12: The first trial date in the federal litigation involving women allegedly injured by vaginal mesh products manufactured by C.R. Bard has been set for early next year. Although the specific lawsuit has yet to be selected, the trial will involve a claim filed on behalf of a woman who allegedly suffered injuries after being implanted with a Bard vaginal mesh product. Click here to learn more.
Free Bard Avaulta Mesh Case Evaluation: If you or a loved one has suffered from complications following surgery in which Bard Avaulta Vaginal Mesh was used, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.
What’s the problem?
Bard Avaulta Mesh is a transvaginal mesh product designed to help manage pelvic organ prolapse (POP), stress urinary incontinence (SUI), and the pain and discomfort that is associated with these conditions. Manufactured by Bard, this model of vaginal mesh has been surgically implanted in hundreds of women during surgery.
Along with other models of vaginal mesh, Bard Avaulta has been linked to serious complications including infection, bladder problems and perforation of the bladder, bowel and blood vessels. Such complications are typically marked by severe pain and discomfort. Treatment may require surgery, blood transfusions, IV therapy, or drainage of hematomas or abscesses.
At the 2004 World Health Organization 3rd International Consultation on Incontinence, it was reported that vaginal mesh procedures have an unacceptably high rate of complications. As a result of the risks, it was recommended that synthetic mesh systems not be used until more approved clinical trials were conducted.
Although the manufacturer, C.R. Bard, knew or should have known about the risk of problems with Bard Avaulta mesh, they continued to market and promote the product as a safe and effective for treatment of pelvic organ prolapse, while minimizing the risks of a Bard Avaulta procedure.
Do I Have a Bard Avaulta Mesh Lawsuit?
The Product Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Bard Avaulta Mesh lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.